Keywords: medarex/b-ms, delay, company, medarex, drug, major, bristol-myers

Medarex/B-MS delay

Article | 05 May 2008

Print This

US company Medarex and drug major Bristol-Myers Squibb will delay the application process for their cancer drug candidate ipilimumab to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in